Contributors | |
Foreword | |
Introduction | |
Overview of Hemostasis | |
Cellular Processing of Factor VIII and IX | |
Work-up of a Bleeding Adult | |
Hemophilia A | |
Molecular Basis of Hemophilia A | |
Hemophilia A: Role of Factor VIII in Coagulation | |
Natural History of Inhibitor Development in Children with Severe Hemophilia A Treated with Factor VIII Products | |
Prophylaxis | |
Continuous Infusion of Coagulation Products in Hemophilia | |
Inhibitors to Factor VIII | |
Inhibitors to Factor VIII - Immunology | |
Inhibitors to Factor VIII - Molecular Basis | |
Inhibitors to Factor VIII - Epidemiology and Treatment | |
Inhibitors to Factor VIII - Mid and Moderate Hemophilia | |
Inhibitors to Factor VIII/IX: Treatment of Inhibitors - Immune Tolerance Induction | |
Inhibitors of Factor VIII: Treatment of Acute Bleeds | |
Acquired Hemophilia | |
Acquired Inhibitors to Factor VIII | |
Hemophilia B | |
Hemophilia B - Molecular Basis | |
Inhibitors in Hemophilia B | |
Treatment Inhibitors in Hemophilia B | |
Pharmacokinetics of Factors VIII & IX | |
Pharmacokinetics | |
Pediatrics | |
Work-up of a Bleeding Child | |
Care of the Child with Hemophilia | |
To Neonate with Hemophilia | |
Products Used to Treat Hemophilia | |
Products Used to Treat Hemophilia: Evolution of Treatment for Hemophilia A and B | |
Products Used to Treat Hemophilia: Recombinant Products | |
Products Used to Treat Hemophilia: Plasma-Derived Coagulation Factor Concentrates | |
Products Used to Treat Hemophilia: Recombinant Factor VIIa | |
Products Used to Treat Hemophilia: Dosing | |
Products Used to Treat Hemophilia: Regulation | |
Muscoskeletal | |
Joint Replacement | |
Synovioarthesis in Hemophilia | |
Pseudotumours in patients with Hemophilia | |
Radiology | |
Magnetic Resonance Imaging/ Joint Outcome | |
Physiotherapy in the Management of Hemophilia | |
Transfusion-Transmitted Disease | |
Transfusion Transmitted Disease: History of Epidemics | |
Transfusion Transmitted Disease: Hepatitis C Virus Infection and Liver Transplantation | |
Gene Therapy | |
Gene Therapy: Introduction and Overview | |
Gene Therapy for Hemophilia B | |
Gene Therapy for Hemophilia A | |
Gene Therapy: Molecular Engineering of Factor VIII and Factor IX | |
Laboratory | |
Laboratory Assays in Hemophilia | |
Standardization of Assays | |
Obstetrics & Gynaecology | |
Obstetrics and Gynecology: Hemophilia | |
Von Willebrand Disease | |
von Willebrand Disease: Molecular Aspects | |
von Willebrand Disease: Epidemiology | |
von Willebrand Disease: Biological Diagnosis | |
47Classification and Clinical Aspects of von Willebrand Disease | |
Treatment of Von Willebrand Disease | |
Treatment of von Willebrand Disease: Desmopressin | |
Treatment of von Willebrand Disease: Therapeutic Concentrates | |
Women & Von Willebrand Disease | |
Rare Bleeding Disorders | |
Factor II | |
Factor V and combined Factor V and VIII Deficiencies | |
Congenital Factor VII Deficiency | |
Factor X and Factor X Deficiency | |
Factor XI Deficiency | |
Factor XIII | |
Fibrinogen | |
Miscellaneous Rare Bleeding Disorders | |
Quality of Life | |
Quality of Life in Hemophilia | |
Economics | |
The Economics of Hemophilia Treatments | |
Comprehensive Care and Delivery of Care | |
Comprehensive Care and Delivery of Care: The Developed World | |
The Comprehensive Care and Delivery of Care: The Developing World | |
Comprehensive Care and Delivery of Care: The Global Perspective | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.